Nicole Back - Concepedia

Author

Nicole Back

Also Known As

Back, Nathan, N Back, N K Back, N K T Back, N. Back, N. K. Back, N. K. T. Back, N.K.T. BACK, N.K.T. Back, NICOLE K. T. BACK

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam GGD Amsterdam University College London Utrecht University

About

Nicole Back is an author at University of Amsterdam specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.1K
2	Natural Sciences	1	1	62
3	Public Health	1	1	39
4	Social Sciences	1	1	17
5	Biomolecular Engineering	1	1	62

Nicole Back

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. Nicole Back, Monique Nijhuis, Wilco Keulen, The EMBO Journal Primary ImmunodeficiencyReverse Transcriptase EnzymeViral ReplicationMedicineViral Polymerase Mechanism	1996	410
An N-Glycan within the Human Immunodeficiency Virus Type 1 gp120 V3 Loop Affects Virus Neutralization Nicole Back, Lia Smit, Jean-Jacques De Jong, Virology Molecular VirologyHuman RetrovirusGlycobiologyImmunologyAntiviral Response	1994	180
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase Wilco Keulen, Nicole Back, Anne‐Eva van der Wijk, Journal of Virology	1997	143
Transmission networks of HIV-1 among men having sex with men in the Netherlands Daniela Bezemer, Ard van Sighem, Vladimir V. Lukashov, AIDS	2009	88
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay Charles A. Boucher, Wilco Keulen, Toon van Bommel, Antimicrobial Agents and Chemotherapy Drug SusceptibilityHiv-1 RnaMedicineHuman RetrovirusImmunology	1996	85
Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains Ben Berkhout, Koen Verhoef, Jeroen L. B. van Wamel, Journal of Virology	1999	84
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study Colette Smit, Anders Boyd, Bart Rijnders, The Lancet HIV Retrospective Cohort StudyTreatment And PreventionHuman RetrovirusHcv Micro-eliminationAntiviral Therapy	2020	72
Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase Nicole Back, Ben Berkhout Antimicrobial Agents and Chemotherapy Viral ReplicationImmunologyMolecular BiologyAntiviral DrugPrimary Cells	1997	62
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies Nicole Back, Linda Smit, Martin Schutten, Journal of Virology ImmunologyMolecular BiologyGp120 AntibodiesImmunotherapyHuman Retrovirus	1993	62
Declining trend in transmission of drug-resistant HIV-1 in Amsterdam Daniela Bezemer, Suzanne Jurriaans, Maria Prins, AIDS	2004	62

Page 1